ArticleDiscover oncology2025

FOXM1 could serve as a bridge mediating prognosis and immunity for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing.

Jianhua Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.